Get started

Investment

Laurus Labs- Potential selling climax has been reached. - Sellers seem exhausted - Continuous divergence on RSI - Moving averages turning flat - Seems like a good pick from the investment perspective. Very interesting turn of events in Laurus Labs after the poor earnings result. In hindsight, it seems like it was a "buy the news" event. Would be interesting to see how it moves over the next few weeks. Disclaimer: This is NOT investment advice. This post is meant for learning purposes only. Invest your capital at your own risk.
NSE:LAURUSLABSLong
by johntradingwick
1
Bata India looking good for Buy Bata India Ltd. (BIL) is the largest retailer and leading manufacturer of footwear in India, with 2,000+ retail stores as of December 2022. We downgrade to Accumulate rating (from Buy) and revise our target price to ₹1,620 (from ₹2,155), factoring current weak demand. Revenue grew by 7 per cebt YoY aided by an improvement in the premium mix. Average selling price (ASP) improved by 13 per cent y-o-y to ₹772. Inflationary pressure and an increased GST rate impacted volumes in mass categories, which is likely to improve gradually. Gross margin improved by 210 bps y-o-y to 54.8 per cent y-o-y, while EBITDA margin improved by 290 bps y-o-y to 22.9 per cent abetted by improved ASP and cost optimisation measures. Bata India targets about 500 franchisees by 2024 and has already opened 392 across 330 towns. This, along with store renovation, portfolio casualisation, and distribution expansion will support volumes. Measures to improve the supply chain and asset light retail expansion, will enhance margins. Given its strong brand recall & reach, we believe, the company can revive its revenue growth trajectory. We value BIL at 43x on FY25 EPS.
NSE:BATAINDIA
by STOCKFORECAST07
► ADVANCE PATTERN #27: ABCAPITAL ◄► ADVANCE PATTERN #27: ABCAPITAL ◄ 📌 Levels are mentioned on chart for ❝Swing trading❞. ☆ Please check the description section ⌨ for early entry level in given stock ₪ to get better Risk to Reward (☈☈) ratio. ☆ Kindly like & share ➥ this pattern. Comment ⎚ with what do you think. Follow me @ tradingview for more updates and like the chart ❤!!! Entry: ▲ 160 SL: ☢ 150 Target: ➚ 210 RR: ☈ 1:5.0 ☆ Thank you. Happy Trading!!! Best Regards, 𝘿𝙧. 𝙎𝙝𝙖𝙢𝙧𝙖𝙟𝙖 𝙉𝙖𝙙𝙖𝙧 𝙋𝙝𝘿 𝙞𝙣 𝙏𝙚𝙘𝙝𝙣𝙤𝙡𝙤𝙜𝙮. ✮ Disclaimer ✮ -------------------------------------------------------- All investments involve risk, and the past performance of a security, industry, sector, market, financial product, trading strategy, or individual’s trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. ---------------------------------------------------------  
NSE:ABCAPITALLong
by Profitable_Traders
Equity Mutual FundsEquity mutual funds have emerged as one of India’s most popular investment options, attracting new and seasoned investors. This article will delve into the various aspects of equity mutual funds, from their investment strategies to their impact on wealth creation. Equity mutual funds have emerged as one of India’s most popular investment options, attracting new and seasoned investors. This section will delve into the different types of equity mutual funds and their investment strategies.
NSE:NIFTY1!
by rishurishab66
Mutual Funds investment mistakes in IndiaIntroduction Investing in mutual funds has become popular for many Indian investors in recent years. It provides an opportunity to invest in a diversified portfolio of assets managed by experienced professionals, with potentially higher returns than traditional investment options such as fixed deposits or savings accounts. Mutual funds also offer flexibility, liquidity, and tax benefits, making them an attractive option for investors seeking financial stability and growth.
TVC:GOLDEducation
by rishurishab66
PAGEIND - Multi-year Retest Zone - Investment/Swing tradeThose who study charts on regular basis, would be familiar that when a stock price breaks its ATH level on a higher Time frame, in majority of cases, it goes much above that level. Similar is the setup in this stock which has been in uptrend for quite long and has shown strength even during market correction recently. The analysis is done on weekly as well as on Daily TF hence price may take few weeks to few months in order to reach the targets. Trade setup is explained in image itself. The above analysis is purely for educational purpose. Traders must do their own study & follow risk management before entering into any trade Checkout my other ideas to understand how one can earn from stock markets with simple trade setups. Feel Free to comment below this or connect with me for any query or suggestion regarding this stock or Price Action Analysis.
NSE:PAGEINDLong
by TradewithAditya
Buy TTK PRESTIGE Target of 850+ Short term trading idea.TTK Group was founded in 1928 founded by Mr. T.T. Krishnamachari who set up the distribution for a wide range of products ranging from Foods, Personal care products, etc. The company is India’s largest kitchenware company. TTK Prestige was Established in 1955 as a private limited company, TTK went public in 1994. It is among the leading brands in the kitchen equipment space, especially in the pressure cooker segment. In 2012 Company had an Alliances with global high-end brands for high-end cookware/Store ware/Water Filters/ Gas-tops. Market Cap ₹ 9,670 Cr. Current Price ₹ 698 High / Low ₹ 1,051 / 666 Stock P/E 35.2 Book Value ₹ 130 Dividend Yield 0.86 % ROCE 24.5 % ROE 18.8 % Face Value ₹ 1.00 Debt ₹ 88.9 Cr. EPS ₹ 19.8 PEG Ratio 2.39 Promoter holding 70.4 % Intrinsic Value ₹ 279 Pledged percentage 0.00 % EVEBITDA 21.7 Company is almost debt free. Company has been maintaining a healthy dividend payout of 23.8% Well company is good for short term as wll as for long term too. If anyone wants to go for long can with given levels on chart. Please follow strict stop loss if you want to go for just trading. If anyone likes my work please like follow and comment. Thankyou
NSE:TTKPRESTIGLong
by TraderRahulPal
InfoBeans Technologies LtdInfoBeans Technologies Ltd is primarily engaged in software development services, specializing in business application development for web and mobile and operate at Capability Maturity Model Integration (CMMI) level 3. Key Clientele The company's clients include companies like American Express, Wework, amazon, Viatech, IQVIA, ALM Media, CoAdvantage and others.The company added 14 clients in FY21 compared to 28 clients in FY20. It caters to 16 Fortune 500 companies. In FY21, USA accounted for ~94% of revenues, followed by Europe (3.3%) and Middle East (2.7%). Its main offices are located in Indore, Bengaluru, Chennai and Pune in India. Accordingly in those days IT sector in the crucial stage and facing like recession as well but I notice the Financial report of this company it shows amazing results and mukul agarwal took a big Stake currently in this company and promoters also having 75% stake. DISCLAIMER - IT'S MY STUDY PONTS NOT ANY RECOMMENDATION. THIS IS ONLY FOR STUDY PURPOSE.
NSE:INFOBEANLong
by EQUITYBROKER
JUBLFOOD : A good opportunity for accumulationJUBLFOOD has experienced a correction of more than 50% from its all-time high, which was achieved in November 2021. When a stock experiences a correction of this magnitude, it may represent a buying opportunity for investors who have a long-term investment horizon. Current price level could represent a good opportunity for accumulation for investors with a long-term investment horizon. It is important to conduct additional research and analysis to ensure that the investment aligns with your financial goals and risk tolerance.
NSE:JUBLFOODLong
by HSJNFinWisdom
1
Best Investment Stock : Target we can see 500% Upside from here.Gujarat Themis Biosyn is principally engaged in the business pertaining to manufacturing of pharmaceuticals and medicinal chemicals. Pioneer in manufacturing Rifampicin The Company entered into Technical & Financial collaboration with Yuhan Corporation, South Korea. With Yuhan’s know-how, GTBL became India’s first Company to start commercial production of Anti-tuberculosis drug Rifampicin. Product Portfolio The Co. is presently manufacturing Rifamycin S, which is an intermediate for manufacturing the drug Rifampicin, and Rifamycin O, which is an intermediate for manufacturing the drug Rifaximin. The production capacity of Rifamycin S is 10,000 kgs/month and that of Rifamycin O is 6,000 kgs/month. Change in Business Model The Company which was doing Job Work for other pharma companies with fixed contracted price changed its business model in FY20 from contract manufacturing to manufacturing and sales model. This seems to have changed the margin profile from ~18% to ~30%. Manufacturing Facility The Co. has a state-of-the-art manufacturing facility at Vapi, Gujarat. Market Cap ₹ 943 Cr. Current Price ₹ 649 High / Low ₹ 921 / 362 Stock P/E 16.8 Book Value ₹ 92.2 Dividend Yield 0.93 % ROCE 66.8 % ROE 50.4 % Face Value ₹ 5.00 Debt ₹ 1.23 Cr. EPS ₹ 38.6 PEG Ratio 0.29 Promoter holding 75.0 % Intrinsic Value ₹ 621 Pledged percentage 0.00 % EVEBITDA 11.8 Company has reduced debt. Company is almost debt free. Company is expected to give good quarter Company has delivered good profit growth of 58.4% CAGR over last 5 years Company has a good return on equity (ROE) track record: 3 Years ROE 56.0% Well i have done my analysis and i found it best investment idea for now. I have written everything on chart and the discription. Please take trade accordingly. guy's i really do hard work to get these analysis. Please support me by like and follow. Thankyou.
BSE:GUJTHEMLong
by TraderRahulPal
4